GeneFerm Biotechnology Co., Ltd.

NT$26.65As of Sun 8 Nov 2026, 12:00 UTC
TPEx:1796Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (10.29%)
Div yield 2.63%
ROE 0.92%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.13
PE TTM 148.5
TSR TTM (43.75%)
Mkt cap NT$1.105B
ROIC 0.82%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$29
7.54%
(55.89%)
Hold 7|8|7|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.59
0.65
0.69
0.76
14.90%
21.46%
28.41%
38.04%
RevenueNT$M
78.56
77.87
81.83
83.30
3.23%
2.27%
3.39%
4.54%
Peers (US$33.37M)
Cap (US$)
PE
32.68M
—
Capital
TTM
5Y
10Y
Leveragex
0.396
(0.301)
(0.190)
EBIT/Intx
1.730
1.150
1.128
Own earn%
(29.69)
87.39
91.24
Sh yield%
25.37
44.96
47.50
Owners
Insiders/Inst%
6.59
64.08
Short interest%
3.32
SBC / revenue%
5.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
16–23
$1 testx
—
Incr. ROIC%
12